左心辅助装置植入治疗心力衰竭的早期结果  

Early results of left ventricular assist device implantation for the treatment of heart failure

作　　者：陈良万[1] 吴青松 戴小福[1] 董疑[1] 李虔桢[1] 方冠华[1] 张贵灿[1] Chen Liangwan;Wu Qingsong;Dai Xiaofu;Dong Yi;Li Qianzhen;Fang Guanhua;Zhang Guican(Department of Cardiovascular Surgery,Union Hospital,Fujian Medical University,Key Laboratory of Cardio-Thoracic Surgery(Fujian Medical University),Fujian Province University,Fuzhou 350001,China)

机构地区：[1]福建医科大学附属协和医院胸心外科,福建省高等学校重点实验室(福建医科大学),福州350001

出　　处：《中华医学杂志》2023年第12期920-923,共4页National Medical Journal of China

基　　金：国家自然科学基金(U2005202)

摘　　要：回顾性分析福建医科大学附属协和医院胸心外科2019年6月至2022年6月因晚期心力衰竭接受左心辅助装置植入治疗的24例患者资料。均为男性,年龄32~61(48.4±8.4)岁,应用Everheat-Ⅰ系统10例,HeartCon系统6例,Corheart 6系统8例。24例患者治疗后均顺利出院,无机械故障和血栓形成,无二次开胸止血。术后早期血流动力学明显改善,左心室缩小,左心室射血分数逐步改善,无溶血发生。随访3~39(17.9±8.6)个月,患者心功能均恢复至Ⅰ~Ⅱ级,6 min步行试验距离明显增加。可见,左心辅助装置植入治疗心力衰竭可获得满意的早期结果。Twenty-four male patients who underwent left ventricular assist device(LVAD)implantation due to advanced heart failure in Union Hospital,Fujian Medical University from June 2019 to June 2022 were retrospectively included.The age of patients was 32-61(48.4±8.4)years.Everheat-Ⅰ,HeartCon and Corheart 6 left ventricular assist systems were used in 10,6 and 8 cases,respectively.All patients were discharged successfully without mechanical failure,thrombosis or secondary thoracotomy for hemostasis.Early postoperative hemodynamics were significantly improved,left ventricular systolic diameter was reduced,left ventricular ejection fraction was gradually improved,and no hemolysis occurred.The patients were followed up for 3 to 39(17.9±8.6)months,the cardiac function was restored to gradeⅠtoⅡ,and the 6-minute walking test distance increased significantly.Therefore,satisfactory early results can be achieved with left ventricular assist device implantation for the treatment of heart failure.

关 键 词：心力衰竭 左心辅助装置 早期结果 

分 类 号：R541.6[医药卫生—心血管疾病]